glioma
The results of the present study show that the anti-diabetic drug troglitazone sensitizes human glioma and neuroblastoma cells to TRAIL-induced apoptosis.
The results of the present study show that the anti-diabetic drug troglitazone sensitizes human <span class="disease" id="16820965-3-96-102">glioma</span> and neuroblastoma cells to <span class="gene" id="16820965-3-130-135">TRAIL</span>-induced apoptosis.